These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

953 related articles for article (PubMed ID: 37914418)

  • 21. [The importance of selecting the right type of inhaler for patients with asthma and chronic obstructive pulmonary disease (COPD)].
    Larsson K; Bjermer L; Svartengren M
    Lakartidningen; 2019 Feb; 116():. PubMed ID: 30720857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerosol delivery devices in the treatment of asthma.
    Hess DR
    Respir Care; 2008 Jun; 53(6):699-723; discussion 723-5. PubMed ID: 18501026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vitro Evaluation of Aerosol Performance and Delivery Efficiency During Mechanical Ventilation Between Soft Mist Inhaler and Pressurized Metered-Dose Inhaler.
    Ke WR; Wang WJ; Lin TH; Wu CL; Huang SH; Wu HD; Chen CC
    Respir Care; 2020 Jul; 65(7):1001-1010. PubMed ID: 32071134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler.
    Biswas R; Hanania NA; Sabharwal A
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):256-266. PubMed ID: 28157430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of inhaler and fine particle on efficacy of inhalation therapy in COPD].
    Sliwiński P; Chazan R; Dąbrowiecki P; Jahnz-Różyk K; Mróz R; Pirożyński M
    Pneumonol Alergol Pol; 2014; 82(3):300-10. PubMed ID: 24793155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion.
    Baloira A; Abad A; Fuster A; García Rivero JL; García-Sidro P; Márquez-Martín E; Palop M; Soler N; Velasco JL; González-Torralba F
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1021-1033. PubMed ID: 33907390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Investigation into the Factors Associated with Incorrect Use of a Pressurized Metered-Dose Inhaler in Japanese Patients.
    Ohnishi H; Okazaki M; Anabuki K; Akita S; Kawase S; Tsuji KS; Miyamura M; Yokoyama A
    J Aerosol Med Pulm Drug Deliv; 2023 Feb; 36(1):12-19. PubMed ID: 36577056
    [No Abstract]   [Full Text] [Related]  

  • 29. The Respimat
    Iwanaga T; Tohda Y; Nakamura S; Suga Y
    Clin Drug Investig; 2019 Nov; 39(11):1021-1030. PubMed ID: 31377981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease.
    Cazzola M; Cavalli F; Usmani OS; Rogliani P
    Expert Opin Drug Deliv; 2020 May; 17(5):635-646. PubMed ID: 32130023
    [No Abstract]   [Full Text] [Related]  

  • 31. Predictors of incorrect inhalation technique in patients with asthma or COPD: a study using a validated videotaped scoring method.
    Rootmensen GN; van Keimpema AR; Jansen HM; de Haan RJ
    J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):323-8. PubMed ID: 20804428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications of the tiotropium/olodaterol inhaler for patients with chronic obstructive pulmonary disease.
    Ferguson GT; Dalby RN
    Postgrad Med; 2018 Aug; 130(6):515-522. PubMed ID: 29972656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Randomized, Crossover Trial Evaluating Patient Handling, Preference, and Ease of Use of the Fluticasone Propionate/Formoterol Breath-Triggered Inhaler.
    Bell D; Mansfield L; Lomax M
    J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):425-434. PubMed ID: 28683212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High inhaler resistance does not limit successful inspiratory maneuver among patients with asthma or COPD.
    Vartiainen VA; Lavorini F; Murphy AC; Rabe KF
    Expert Opin Drug Deliv; 2023 Mar; 20(3):385-393. PubMed ID: 36820500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novolizer: how does it fit into inhalation therapy?
    Magnussen H
    Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Device mechanics and evaluation of inspiratory flow rate required of the beclomethasone dipropionate breath-actuated inhaler.
    Mansfield LE; Hampel FC; Sfeir B; Small CJ; Walsh D; Dunphy L
    Allergy Asthma Proc; 2019 May; 40(3):162-166. PubMed ID: 31018890
    [No Abstract]   [Full Text] [Related]  

  • 38. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
    Henriet AC; Marchand-Adam S; Mankikian J; Diot P
    Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demystifying Dry Powder Inhaler Resistance with Relevance to Optimal Patient Care.
    Capstick TGD; Gudimetla S; Harris DS; Malone R; Usmani OS
    Clin Drug Investig; 2024 Feb; 44(2):109-114. PubMed ID: 38198116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.